Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Blackrock
BLK
$182B
| $6.35M | ﹤0.01% |
13,535
-108,745
| -89% | -$49.2M |
|
2602
CALL
Iovance Biotherapeutics
IOVA
$3.16B
| $6.34M | ﹤0.01% |
+258,600
| New | +$3.9M |
|
2603
Alamos Gold
AGI
$14B
| $6.34M | ﹤0.01% |
1,048,044
+934,759
| +825% | +$4.65M |
|
|
TELL
2604
DELISTED
Tellurian Inc.
TELL
| $6.34M | ﹤0.01% |
807,211
+623,581
| +340% | +$5.54M |
|
2605
Acadia Realty Trust
AKR
$2.86B
| $6.31M | ﹤0.01% |
230,585
+157,497
| +215% | +$4.42M |
|
2606
CALL
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $6.31M | ﹤0.01% |
148,400
+16,000
| +12% | +$673K |
|
|
ARQL
2607
DELISTED
Arqule Inc
ARQL
| $6.31M | ﹤0.01% |
572,743
+486,108
| +561% | +$3.38M |
|
2608
CALL
Helmerich & Payne
HP
$4.42B
| $6.3M | ﹤0.01% |
124,400
+29,000
| +30% | +$1.6M |
|
2609
Workiva
WK
$3.84B
| $6.3M | ﹤0.01% |
108,409
-423,888
| -80% | -$22.7M |
|
|
XENT
2610
DELISTED
Intersect ENT, Inc
XENT
| $6.3M | ﹤0.01% |
276,683
+251,273
| +989% | +$6.78M |
|
2611
H&R Block
HRB
$6.83B
| $6.29M | ﹤0.01% |
214,857
-734,697
| -77% | -$19.7M |
|
2612
Toro Company
TTC
$9.37B
| $6.29M | ﹤0.01% |
94,104
-10,092
| -10% | -$708K |
|
2613
CALL
AstraZeneca
AZN
$243B
| $6.27M | ﹤0.01% |
75,950
-7,850
| -9% | -$616K |
|
2614
ProShares UltraPro QQQ
TQQQ
$38.5B
| $6.27M | ﹤0.01% |
811,928
-629,728
| -44% | -$4.73M |
|
|
TMX
2615
DELISTED
Terminix Global Holdings, Inc.
TMX
| $6.26M | ﹤0.01% |
120,223
+63,154
| +111% | +$3.25M |
|
|
KSU
2616
PUT
DELISTED
Kansas City Southern
KSU
| $6.26M | ﹤0.01% |
51,400
-21,500
| -29% | -$2.57M |
|
2617
CALL
Vistra
VST
$49.7B
| $6.25M | ﹤0.01% |
276,300
+66,400
| +32% | +$1.66M |
|
|
AXON
2618
PUT
Axon Enterprise
AXON
$49.8B
| $6.25M | ﹤0.01% |
97,300
+45,300
| +87% | +$2.95M |
|
2619
CALL
AngloGold Ashanti
AU
$48.7B
| $6.23M | ﹤0.01% |
350,000
-31,800
| -8% | -$427K |
|
2620
Bank of Montreal
BMO
$130B
| $6.23M | ﹤0.01% |
82,499
+9,171
| +13% | +$702K |
|
2621
CALL
Yeti Holdings
YETI
$3.25B
| $6.23M | ﹤0.01% |
215,200
+113,600
| +112% | +$3.27M |
|
2622
PUT
Cardinal Health
CAH
$54.7B
| $6.23M | ﹤0.01% |
132,200
-17,900
| -12% | -$826K |
|
2623
CALL
Guardant Health
GH
$21.1B
| $6.22M | ﹤0.01% |
72,100
+49,000
| +212% | +$3.74M |
|
2624
CALL
Harley-Davidson
HOG
$2.89B
| $6.22M | ﹤0.01% |
173,600
-114,400
| -40% | -$4.16M |
|
2625
CALL
eHealth
EHTH
$39.1M
| $6.22M | ﹤0.01% |
72,200
+14,100
| +24% | +$949K |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.